Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Debt / NOTE 2.625% 2/1
-
Number of holders
-
14
-
Total 13F principal, excl. options
-
130,974,100
-
Principal change
-
+1,162,500
-
Total reported value, excl. options
-
$126,245,995
-
Value change
-
+$2,987,304
-
Number of buys
-
4
-
Number of sells
-
2
-
Price
-
$0.8602
Institutional Holders of COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 as of Q3 2022
As of 30 Sep 2022 COLLEGIUM PHARMACEUTICAL INC - NOTE 2.625% 2/1 had 15 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $130,974,100 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, LAZARD ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, Linden Advisors LP, AQR Arbitrage LLC, MACQUARIE GROUP LTD, Jefferies Group LLC, Verition Fund Management LLC, CALAMOS ADVISORS LLC, and MORGAN STANLEY.
This table shows 15 bond principal holders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.